Science & Medicine

Sanofi out of the JAK2-MF Biz



Sanofi’s JAK-2 Drug Kaput!

Farewell to Federatnib…we hardly knew ya’

In a stunning and unexpected announcement this morning, Sanofi pulled the plug on clinical trials and filings for its MF JAK-2 inhibitor SAR 302503(federatnib).

Here’s the text:

Sanofi release over

Comments on: "Sanofi out of the JAK2-MF Biz" (2)

  1. jsandresen1 said:

    Of course you never want to a lose company whose developing drugs for a potnetial cure for MF.

  2. Jeremy Smith said:

    This is a huge surpise I assume their drug did not work.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: